Literature DB >> 17148669

Oval cell response in 2-acetylaminofluorene/partial hepatectomy rat is attenuated by short interfering RNA targeted to stromal cell-derived factor-1.

Donghang Zheng1, Seh-hoon Oh, Youngmi Jung, Bryon E Petersen.   

Abstract

Stromal cell-derived factor-1 (SDF-1) is known to play an essential role in the regulation of stem/progenitor cell trafficking. During hepatic stem, or oval, cell activation, SDF-1 has been reported to be up-regulated within the liver, implying a possible role in oval cell-aided liver regeneration. In the present study, SDF-1 expression was knocked down in the liver of 2-acetylaminofluorene/partial hepatectomy-treated rats using short interfering RNA delivered by recombinant adenovirus. The oval cell response was compromised in these animals, as evidenced by a decreased number of OV6-positive oval cells. In addition, knockdown of SDF-1 expression caused a dramatic decrease in alpha-fetoprotein expression, implying impaired oval cell activation in these animals. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling assay showed no significant apoptosis related to SDF-1 suppression. Instead, as revealed by Ki67 immunohistochemistry, the suppression of SDF-1 resulted in decrease of hepatic cell proliferation, implying the repair process had been inhibited in these animals. These results indicate that SDF-1 is an essential molecule needed in oval cell activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17148669      PMCID: PMC1762488          DOI: 10.2353/ajpath.2006.060211

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow.

Authors:  M Z Ratajczak; M Kucia; R Reca; M Majka; A Janowska-Wieczorek; J Ratajczak
Journal:  Leukemia       Date:  2004-01       Impact factor: 11.528

2.  SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats.

Authors:  Heather M Hatch; Donghang Zheng; Marda L Jorgensen; Bryon E Petersen
Journal:  Cloning Stem Cells       Date:  2002

3.  Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt.

Authors:  Simone Barbero; Rudy Bonavia; Adriana Bajetto; Carola Porcile; Paolo Pirani; Jean Louis Ravetti; Gian Luigi Zona; Renato Spaziante; Tullio Florio; Gennaro Schettini
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

4.  Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells.

Authors:  Hal E Broxmeyer; Lisa Kohli; Chang H Kim; Younghee Lee; Charlie Mantel; Scott Cooper; Giao Hangoc; Montaser Shaheen; Xiaxin Li; D Wade Clapp
Journal:  J Leukoc Biol       Date:  2003-05       Impact factor: 4.962

5.  Apoptotic pathway related to oval cell proliferation.

Authors:  Yoshihiko Yano; Yoshitake Hayashi; Tadahisa Teramoto; Miyuki Nakaji; Peter Nagy; Toshiaki Ninomiya; Atsushi Wada; Midori Hirai; Soo Ryang Kim; Yasushi Seo; Seitetsu Yoon; Masato Kasuga
Journal:  J Gastroenterol Hepatol       Date:  2004-08       Impact factor: 4.029

6.  Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny.

Authors:  Toshiaki Ara; Koji Tokoyoda; Tatsuki Sugiyama; Takeshi Egawa; Kenji Kawabata; Takashi Nagasawa
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

7.  HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver.

Authors:  Orit Kollet; Shoham Shivtiel; Yuan-Qing Chen; Jenny Suriawinata; Swan N Thung; Mariana D Dabeva; Joy Kahn; Asaf Spiegel; Ayelet Dar; Sarit Samira; Polina Goichberg; Alexander Kalinkovich; Fernando Arenzana-Seisdedos; Arnon Nagler; Izhar Hardan; Michel Revel; David A Shafritz; Tsvee Lapidot
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

8.  Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo.

Authors:  Hal E Broxmeyer; Scott Cooper; Lisa Kohli; Giao Hangoc; Younghee Lee; Charlie Mantel; D Wade Clapp; Chang H Kim
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

9.  A precursor-product relationship exists between oval cells and hepatocytes in rat liver.

Authors:  R P Evarts; P Nagy; E Marsden; S S Thorgeirsson
Journal:  Carcinogenesis       Date:  1987-11       Impact factor: 4.944

10.  The chemokine SDF1/CXCL12 and its receptor CXCR4 regulate mouse germ cell migration and survival.

Authors:  Kathleen A Molyneaux; Hélène Zinszner; Prabhat S Kunwar; Kyle Schaible; Jürg Stebler; Mary Jean Sunshine; William O'Brien; Erez Raz; Dan Littman; Chris Wylie; Ruth Lehmann
Journal:  Development       Date:  2003-09       Impact factor: 6.868

View more
  14 in total

Review 1.  Biology of the adult hepatic progenitor cell: "ghosts in the machine".

Authors:  Houda Darwiche; Bryon E Petersen
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 2.  Liver regeneration.

Authors:  George K Michalopoulos
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

Review 3.  Potential applications for cell regulatory factors in liver progenitor cell therapy.

Authors:  Thomas Shupe; Bryon E Petersen
Journal:  Int J Biochem Cell Biol       Date:  2010-09-21       Impact factor: 5.085

4.  Increased susceptibility to severe chronic liver damage in CXCR4 conditional knock-out mice.

Authors:  Atsunori Tsuchiya; Michitaka Imai; Hiroteru Kamimura; Masaaki Takamura; Satoshi Yamagiwa; Tatsuki Sugiyama; Minoru Nomoto; Toshio Heike; Takashi Nagasawa; Tatsutoshi Nakahata; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2012-06-05       Impact factor: 3.199

Review 5.  Dipeptidyl peptidase-4: a key player in chronic liver disease.

Authors:  Minoru Itou; Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

6.  Management of Liver Failure: From Transplantation to Cell-Based Therapy.

Authors:  Maria Giovanna Francipane; Melchiorre Cervello; Giovanni Battista Vizzini; Giada Pietrosi; Giuseppe Montalto
Journal:  Cell Med       Date:  2011-06-01

7.  Inhibition of the CXCL12/CXCR4 chemokine axis with AMD3100, a CXCR4 small molecule inhibitor, worsens murine hepatic injury.

Authors:  Yedidya Saiman; JingJing Jiao; M Isabel Fiel; Scott L Friedman; Costica Aloman; Meena B Bansal
Journal:  Hepatol Res       Date:  2014-10-07       Impact factor: 4.288

Review 8.  Activation of stem cells in hepatic diseases.

Authors:  T G Bird; S Lorenzini; S J Forbes
Journal:  Cell Tissue Res       Date:  2007-11-29       Impact factor: 5.249

9.  Hypoxia upregulates Cxcl12 in hepatocytes by a complex mechanism involving hypoxia-inducible factors and transforming growth factor-β.

Authors:  Jenna Strickland; Domonique Garrison; Bryan L Copple
Journal:  Cytokine       Date:  2020-01-14       Impact factor: 3.861

Review 10.  Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.

Authors:  Ismael Ghanem; Maria E Riveiro; Valerie Paradis; Sandrine Faivre; Paula M Vázquez de Parga; Eric Raymond
Journal:  Am J Transl Res       Date:  2014-07-18       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.